The Value of Routine Pharmacogenomic Screening – Are We There Yet?: A perspective on the costs and benefits of routine ADMET and HLA profiling – Shouldn’t everyone have this done?...

由 Veenstra, David L.
發表在 Clin Pharmacol Ther (2015)

Evolving research and stakeholder perspectives on pharmacogenomics

由 Beitelshees, Amber L., Veenstra, David L.
出版 2011

A FRAMEWORK FOR PRIORITIZING RESEARCH INVESTMENTS IN PRECISION MEDICINE

由 Basu, Anirban, Carlson, Josh J., Veenstra, David L.
發表在 Med Decis Making (2015)

Assessing the cost-effectiveness of pharmacogenomics

由 Veenstra, David L., Higashi, Mitchell K., Phillips, Kathryn A.
出版 2000

Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis

由 Serbin, Michael A., Guzauskas, Gregory F., Veenstra, David L.
發表在 J Manag Care Spec Pharm (2016)

Modeling the Cost and Outcomes of Pharmacist-Prescribed Emergency Contraception

由 Marciante, Kristin D., Gardner, Jacqueline S., Veenstra, David L., Sullivan, Sean D.
出版 2001

The Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting

由 Hart, Ragan, Veenstra, David L., Boudreau, Denise M., Roth, Joshua A.
發表在 Am J Med (2016)

Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experiment

由 Weymann, Deirdre, Veenstra, David L., Jarvik, Gail P., Regier, Dean A.
發表在 Eur J Hum Genet (2018)

CDR State Transition Probabilities in Alzheimer's Disease with and without Cholinesterase Inhibitor Intervention in an Observational Cohort

由 Bloudek, Lisa M., Spackman, D. Eldon, Veenstra, David L., Sullivan, Sean D.
出版 2011

Artificial intelligence in breast cancer screening: primary care provider preferences

由 Hendrix, Nathaniel, Hauber, Brett, Lee, Christoph I, Bansal, Aasthaa, Veenstra, David L
發表在 J Am Med Inform Assoc (2020)

Paying for personalized care: Cancer biomarkers and comparative effectiveness

由 Thariani, Rahber, Veenstra, David L., Carlson, Josh J., Garrison, Louis P., Ramsey, Scott
出版 2012

Long-term Survival in Patients with Severe Acute Respiratory Distress Syndrome and Rescue Therapies for Refractory Hypoxemia

由 Khandelwal, Nita, Hough, Catherine L., Bansal, Aasthaa, Veenstra, David L., Treggiari, Miriam M.
出版 2014

The cost-effectiveness of returning incidental findings from next-generation genomic sequencing

由 Bennette, Caroline S., Gallego, Carlos J., Burke, Wylie, Jarvik, Gail P., Veenstra, David L.
發表在 Genet Med (2014)

Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting

由 Roth, Joshua A., Bradley, Katharine, Thummel, Kenneth E., Veenstra, David L., Boudreau, Denise
發表在 Pharmacoepidemiol Drug Saf (2015)

Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities

由 Conti, Rena, Veenstra, David L., Armstrong, Katrina, Lesko, Lawrence J., Grosse, Scott D.
發表在 Med Decis Making (2010)

Are evidence standards different for genomic- vs. clinical-based precision medicine? - A quantitative analysis of individualized warfarin therapy

由 Dhanda, Devender S., Guzauskas, Gregory F., Carlson, Josh J., Basu, Anirban, Veenstra, David L.
發表在 Clin Pharmacol Ther (2017)

Are there different evidence thresholds for genomic vs. clinical precision medicine? A VOI-based framework applied to antiplatelet drug therapy

由 Guzauskas, Gregory F., Basu, Anirban, Serbin, Michael, Carlson, Josh J., Veenstra, David L.
發表在 Value Health (2019)

Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support

由 Hoath James I, Tarczy-Hornoch Peter, Overby Casey, Kalet Ira J, Veenstra David L
出版 2010-10-01

A Formal Risk-Benefit Framework for Genomic Tests: Facilitating the Appropriate Translation of Genomics Into Clinical Practice

由 Veenstra, David L., Roth, Joshua A., Garrison, Louis P., Ramsey, Scott D., Burke, Wylie
出版 2010

The Value of Comparative Effectiveness Research: Projected Return on Investment of the RxPONDER Trial (SWOG S1007)

由 Wong, William, Ramsey, Scott D., Barlow, William E., Garrison, Louis P., Veenstra, David L.
出版 2012